Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP439623.RAtMypj4-wn8nBqrgRYNmX60xTR1lqQbvoanqIxuV3M68130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP439623.RAtMypj4-wn8nBqrgRYNmX60xTR1lqQbvoanqIxuV3M68130_assertion type Assertion NP439623.RAtMypj4-wn8nBqrgRYNmX60xTR1lqQbvoanqIxuV3M68130_head.
- NP439623.RAtMypj4-wn8nBqrgRYNmX60xTR1lqQbvoanqIxuV3M68130_assertion description "[Acquired mutations in GATA1 were detected in the vast majority of patients with acute megakaryoblastic leukemia (DS-AMKL) and in nearly every patient with transient myeloproliferative disorder (TMD), a `preleukemia` that may be present in as many as 10% of infants with DS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP439623.RAtMypj4-wn8nBqrgRYNmX60xTR1lqQbvoanqIxuV3M68130_provenance.
- NP439623.RAtMypj4-wn8nBqrgRYNmX60xTR1lqQbvoanqIxuV3M68130_assertion evidence source_evidence_literature NP439623.RAtMypj4-wn8nBqrgRYNmX60xTR1lqQbvoanqIxuV3M68130_provenance.
- NP439623.RAtMypj4-wn8nBqrgRYNmX60xTR1lqQbvoanqIxuV3M68130_assertion SIO_000772 14512321 NP439623.RAtMypj4-wn8nBqrgRYNmX60xTR1lqQbvoanqIxuV3M68130_provenance.
- NP439623.RAtMypj4-wn8nBqrgRYNmX60xTR1lqQbvoanqIxuV3M68130_assertion wasDerivedFrom befree-20140225 NP439623.RAtMypj4-wn8nBqrgRYNmX60xTR1lqQbvoanqIxuV3M68130_provenance.
- NP439623.RAtMypj4-wn8nBqrgRYNmX60xTR1lqQbvoanqIxuV3M68130_assertion wasGeneratedBy ECO_0000203 NP439623.RAtMypj4-wn8nBqrgRYNmX60xTR1lqQbvoanqIxuV3M68130_provenance.